These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 18276020

  • 21. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
    Sajic D, Ashkar AA, Patrick AJ, McCluskie MJ, Davis HL, Levine KL, Holl R, Rosenthal KL.
    J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
    [Abstract] [Full Text] [Related]

  • 22. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA.
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [Abstract] [Full Text] [Related]

  • 23. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
    Morrison LA, Da Costa XJ, Knipe DM.
    Virology; 1998 Mar 30; 243(1):178-87. PubMed ID: 9527927
    [Abstract] [Full Text] [Related]

  • 24. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I, Zhang X, Afifi RE, BenMohamed L.
    Viral Immunol; 2006 Mar 30; 19(2):220-36. PubMed ID: 16817765
    [Abstract] [Full Text] [Related]

  • 25. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL.
    Lab Invest; 1994 Mar 30; 70(3):369-80. PubMed ID: 8145530
    [Abstract] [Full Text] [Related]

  • 26. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M, Soleimanjahi H, Fotouhi F, Pakravan N.
    Comp Immunol Microbiol Infect Dis; 2009 Sep 30; 32(5):453-61. PubMed ID: 18571235
    [Abstract] [Full Text] [Related]

  • 27. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE, Tang VA, Towarnicki KM, Rosenthal KL, Kaushic C.
    J Virol; 2005 Mar 30; 79(5):3117-26. PubMed ID: 15709031
    [Abstract] [Full Text] [Related]

  • 28. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ, Morrison LA, Knipe DM.
    Virology; 2001 Sep 30; 288(2):256-63. PubMed ID: 11601897
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC, Barban V, Pradezynski F, de Montfort A, Ryall R, Caillet C, Londono-Hayes P.
    PLoS One; 2015 Sep 30; 10(4):e0121518. PubMed ID: 25837802
    [Abstract] [Full Text] [Related]

  • 30. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.
    FEMS Immunol Med Microbiol; 2007 Feb 30; 49(1):46-55. PubMed ID: 17094789
    [Abstract] [Full Text] [Related]

  • 31. Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.
    Görander S, Harandi AM, Lindqvist M, Bergström T, Liljeqvist JÅ.
    J Virol; 2012 Jul 30; 86(14):7544-53. PubMed ID: 22553328
    [Abstract] [Full Text] [Related]

  • 32. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR, Niu B, Wang JW, Feng ZJ, Wang DX.
    Acta Virol; 2006 Jul 30; 50(4):251-6. PubMed ID: 17177610
    [Abstract] [Full Text] [Related]

  • 33. A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.
    Halford WP, Püschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B.
    PLoS One; 2011 Mar 11; 6(3):e17748. PubMed ID: 21412438
    [Abstract] [Full Text] [Related]

  • 34. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
    Gill N, Ashkar AA.
    Eur J Immunol; 2007 Sep 11; 37(9):2529-38. PubMed ID: 17668897
    [Abstract] [Full Text] [Related]

  • 35. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K, Ekblad M, Görander S, Bergström T, Liljeqvist JÅ.
    Viruses; 2016 Apr 22; 8(4):110. PubMed ID: 27110813
    [Abstract] [Full Text] [Related]

  • 36. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA, Rosenthal KL.
    J Reprod Immunol; 2010 Dec 22; 87(1-2):39-44. PubMed ID: 20688399
    [Abstract] [Full Text] [Related]

  • 37. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
    Dumais N, Patrick A, Moss RB, Davis HL, Rosenthal KL.
    J Infect Dis; 2002 Oct 15; 186(8):1098-105. PubMed ID: 12355360
    [Abstract] [Full Text] [Related]

  • 38. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A.
    J Virol; 2006 Feb 15; 80(4):1752-61. PubMed ID: 16439532
    [Abstract] [Full Text] [Related]

  • 39. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
    Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT.
    J Virol; 2015 Jan 15; 89(1):83-96. PubMed ID: 25320297
    [Abstract] [Full Text] [Related]

  • 40. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    Milligan GN, Dudley-McClain KL, Young CG, Chu CF.
    J Reprod Immunol; 2004 Apr 15; 61(2):115-27. PubMed ID: 15063634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.